| For: | Semmo N, Klenerman P. CD4+ T cell responses in hepatitis C virus infection. World J Gastroenterol 2007; 13(36): 4831-4838 [PMID: 17828814 DOI: 10.3748/wjg.v13.i36.4831] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i36/4831.htm |
| Number | Citing Articles |
| 1 |
Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy. Pathogens 2021; 10(11) doi: 10.3390/pathogens10111488
|
| 2 |
Cordelia Manickam, Amanda J. Martinot, Rhianna A. Jones, Valerie Varner, R. Keith Reeves. Hepatic immunopathology during occult hepacivirus re-infection. Virology 2017; 512 doi: 10.1016/j.virol.2017.08.037
|
| 3 |
Zoia R. Korobova, Natalia A. Arsentieva, Anastasia A. Butenko, Oleg K. Batsunov, Natalia E. Lyubimova, Yulia V. Ostankova, Ekaterina V. Anufrieva, Sergey A. Maslov, Konstantin V. Kozlov, Dmitrii L. Sulima, Oksana Yu. Rishnyak, Areg A. Totolian. Disease-Associated Shifts in Minor T Cell Subpopulations Define Distinct Immunopathology in HBV vs. HCV Infection. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26167761
|
| 4 |
Xinjian Zhang, Jun Dou, Markus W. Germann. Characterization of the cellular immune response in hepatitis C virus infection. Medicinal Research Reviews 2009; 29(6) doi: 10.1002/med.20157
|
| 5 |
Mark AA Claassen, Harry LA Janssen, André Boonstra. Role of T cell immunity in hepatitis C virus infections. Current Opinion in Virology 2013; 3(4) doi: 10.1016/j.coviro.2013.05.006
|
| 6 |
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani, Azam Bolhassani. The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Review of Vaccines 2021; 20(7) doi: 10.1080/14760584.2021.1941895
|
| 7 |
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
|
| 8 |
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
|
| 9 |
Andre Boonstra, Andrea M. Woltman, Harry L.A. Janssen. Immunology of hepatitis B and hepatitis C virus infections. Best Practice & Research Clinical Gastroenterology 2008; 22(6) doi: 10.1016/j.bpg.2008.11.015
|
| 10 |
Naglaa H. Shoukry. Hepatitis C Vaccines, Antibodies, and T Cells. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01480
|
| 11 |
Song Chunhui, Chen Liming, Yang Bin, Chi Shuping, Cheng Yun. Seven amino acid peptide mimic from HVR1 of HCV influences cytokine profile of immune cells. Journal of Medical Colleges of PLA 2010; 25(5) doi: 10.1016/S1000-1948(11)60011-7
|
| 12 |
Cinthya Alicia Marcela López, Rosa Nicole Freiberger, Franco Agustín Sviercz, Jorge Quarleri, María Victoria Delpino. HIV-Infected Hepatic Stellate Cells or HCV-Infected Hepatocytes Are Unable to Promote Latency Reversal among HIV-Infected Mononuclear Cells. Pathogens 2024; 13(2) doi: 10.3390/pathogens13020134
|
| 13 |
A. N. Belyavtsev, N. S. Shastina, V. V. Kupriyanov, L. I. Nikolaeva, M. V. Melnikova, E. F. Kolesanova, M. Yu. Shimchishina, I. V. Kapustin. Effect of Lipid Components on Immunogenicity of Synthetic Fragment of Hepatitis C Virus NS4A Antigen. Russian Journal of Bioorganic Chemistry 2022; 48(3) doi: 10.1134/S1068162022030049
|
| 14 |
Julian Schulze zur Wiesch, Donatella Ciuffreda, Lia Lewis-Ximenez, Victoria Kasprowicz, Brian E. Nolan, Hendrik Streeck, Jasneet Aneja, Laura L. Reyor, Todd M. Allen, Ansgar W. Lohse, Barbara McGovern, Raymond T. Chung, William W. Kwok, Arthur Y. Kim, Georg M. Lauer. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. Journal of Experimental Medicine 2012; 209(1) doi: 10.1084/jem.20100388
|
| 15 |
Isabela S. Oliveira, Lucas P. Carvalho, Maria Isabel Schinoni, Raymundo Paraná, Ajax M. Atta, Maria Luiza B. Sousa Atta. Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin. Microbial Pathogenesis 2016; 91 doi: 10.1016/j.micpath.2015.12.007
|
| 16 |
L. Alvarez‐Lajonchere, N. H. Shoukry, B. Grá, Y. Amador‐Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González‐Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas‐Carrera. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 2009; 16(3) doi: 10.1111/j.1365-2893.2008.01058.x
|
| 17 |
Timothy T. Spear, Glenda G. Callender, Jeffrey J. Roszkowski, Kelly M. Moxley, Patricia E. Simms, Kendra C. Foley, David C. Murray, Gina M. Scurti, Mingli Li, Justin T. Thomas, Alexander Langerman, Elizabeth Garrett-Mayer, Yi Zhang, Michael I. Nishimura. TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors. Cancer Immunology, Immunotherapy 2016; 65(3) doi: 10.1007/s00262-016-1800-2
|
| 18 |
Michael A. Nalesnik, Tatsuya Kanto. Natural Killer Cells. 2010; doi: 10.1016/B978-0-12-370454-2.00044-2
|
| 19 |
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Molecular Diagnosis & Therapy 2009; 13(3) doi: 10.1007/BF03256323
|
| 20 |
KASHIF ASGHAR, M. TAIMOUR ASHIQ, BILAL ZULFIQAR, AMNAH MAHROO, KAENAT NASIR, SHEEBA MURAD. Indoleamine 2,3-dioxygenase expression and activity in patients with hepatitis C virus-induced liver cirrhosis. Experimental and Therapeutic Medicine 2015; 9(3) doi: 10.3892/etm.2014.2146
|
| 21 |
Arshi Khanam, Shyamasundaran Kottilil, Eleanor Wilson. Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77020-2
|
| 22 |
Yan Zhou, Benoît Callendret, Dan Xu, Kathleen M. Brasky, Zongdi Feng, Lucinda L. Hensley, Jeremie Guedj, Alan S. Perelson, Stanley M. Lemon, Robert E. Lanford, Christopher M. Walker. Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection. Journal of Experimental Medicine 2012; 209(8) doi: 10.1084/jem.20111906
|
| 23 |
Aya I. Abdelaziz, Eman Abdelsameea, Sara A. Wahdan, Doaa Elsherbiny, Zeinab Zakaria, Samar S. Azab. Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01811-y
|
| 24 |
M. Bes, S. Sauleda, N. Casamitjana, M. Piron, I. Campos‐Varela, J. Quer, M. Cubero, L. Puig, J. Guardia, J. I. Esteban. Reversal of nonstructural protein 3‐specific CD4+ T cell dysfunction in patients with persistent hepatitis C virus infection. Journal of Viral Hepatitis 2012; 19(4) doi: 10.1111/j.1365-2893.2011.01549.x
|
| 25 |
Justyna Kaźmierczak, Kamila Caraballo Cortes, Iwona Bukowska-Ośko, Marek Radkowski. Virus-Specific Cellular Response in Hepatitis C Virus Infection. Archivum Immunologiae et Therapiae Experimentalis 2016; 64(2) doi: 10.1007/s00005-015-0364-8
|
| 26 |
Sheikh Abdul Rahman, Sailaja Gangadhara, John Gridley, Uchurappa Mala, Elizabeth J. Elrod, Nathalie Bédard, Julie Bruneau, Naglaa H. Shoukry, Arash Grakoui, Rama Rao Amara. T- and B-cell–targeting DNA/MVA HCV vaccines induce strong and broad cellular and humoral immunity in mice and rhesus macaques. Hepatology 2026; doi: 10.1097/HEP.0000000000001732
|
| 27 |
Elisavet Serti, Polyxeni P. Doumba, George Thyphronitis, Panagiota Tsitoura, Konstantina Katsarou, Pelagia Foka, Manousos M. Konstandoulakis, John Koskinas, Penelope Mavromara, Urania Georgopoulou. Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cellular and Molecular Life Sciences 2011; 68(3) doi: 10.1007/s00018-010-0466-8
|
| 28 |
H.I. Basha, V. Subramanian, A. Seetharam, D.S. Nath, S. Ramachandran, C.D. Anderson, S. Shenoy, W.C. Chapman, J.S. Crippin, T. Mohanakumar. Characterization of HCV-Specific CD4+Th17 Immunity in Recurrent Hepatitis C–Induced Liver Allograft Fibrosis. American Journal of Transplantation 2011; 11(4) doi: 10.1111/j.1600-6143.2011.03458.x
|
| 29 |
Polyxeni P. Doumba, Elisavet Serti, Maria Boutsikou, Manousos M. Konstadoulakis, Urania Georgopoulou, John Koskinas. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake. Cellular and Molecular Life Sciences 2013; 70(18) doi: 10.1007/s00018-013-1344-y
|
| 30 |
Elena Removna Chernykh, Ekaterina Alexandrovna Oleynik, Olga Yur’evna Leplina, Natalya Mihaylovna Starostina, Alexander Anatolievich Ostanin. Dendritic cells in the pathogenesis of viral hepatitis C. Russian Journal of Infection and Immunity 2019; 9(2) doi: 10.15789/2220-7619-2019-2-239-252
|
| 31 |
Mona M Rafik, Alaa El-Dien MS Hosny, Khaled O Abdallah, Amal A Abbas, Rania A Abo Shady, Dina A Soliman, Khaled M Nasr El-Din Rakha, Shahira F Alfedawy. TH1 cytokine response to HCV peptides in Egyptian health care workers: a pilot study. Virology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-144
|
| 32 |
Palma A. Iacovazzi, Raffaele Cozzolongo, Elsa Lanzillotta, Stefania Frisullo, Vito Guerra, Mario Correale. Serum 90K/Mac-2 Binding Protein (Mac-2BP) as a Response Predictor to Peginterferon and Ribavirin Combined Treatment in Hcv Chronic Patients. Immunopharmacology and Immunotoxicology 2008; 30(4) doi: 10.1080/08923970802278177
|
| 33 |
Sumathi Ramachandran, David S. Campo, Zoya E. Dimitrova, Guo-liang Xia, Michael A. Purdy, Yury E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic Infection. Journal of Virology 2011; 85(13) doi: 10.1128/JVI.02204-10
|
| 34 |
Sarthak Basak, Arindam Ghosh, Anirban Biswas, Debosmita Bhattacharya, Priti Thakur, Sumana Roy, Saikat Mukherjee, Pronabesh Ghosh, Soubhik Ghosh, Arindam Bhattacharyya. Role and Interrelationship Between Myeloid-Derived Suppressor Cells and CD4+ T Cells in Different Types of Infections: A Review. Proceedings of the Zoological Society 2024; 77(1) doi: 10.1007/s12595-023-00510-4
|
| 35 |
Daniel M. Andrews, Marie J. Estcourt, Christopher E. Andoniou, Matthew E. Wikstrom, Andrea Khong, Valentina Voigt, Peter Fleming, Hyacinth Tabarias, Geoffrey R. Hill, Robbert G. van der Most, Anthony A. Scalzo, Mark J. Smyth, Mariapia A. Degli-Esposti. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. Journal of Experimental Medicine 2010; 207(6) doi: 10.1084/jem.20091193
|
| 36 |
E.A. Egorova, T.M. Melnikova, M.V. Melnikova, M.G. Zavyalova, L.V. Kostryukova, O.V. Chibiskova, R.I. Ataullakhanov, E.F. Kolesanova. The Influence of Adjuvants on Antigenic Properties of Peptide Constructs Composed of Hepatitis C Virus Envelope Protein E2 Fragments. Biomedical Chemistry: Research and Methods 2025; 8(1) doi: 10.18097/BMCRM00227
|
| 37 |
Vijayamahantesh Vijayamahantesh, Tapas Patra, Keith Meyer, Mohamad-Gabriel Alameh, Erin K. Reagan, Drew Weissman, Ranjit Ray, J.-H. James Ou. Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response. Journal of Virology 2022; 96(12) doi: 10.1128/jvi.00523-22
|
| 38 |
Helal F. Hetta, Asmaa M. Zahran, Shima G. Mansor, Mohamed O. Abdel‐Malek, Mohamed A. Mekky, Wael A. Abbas. Frequency and Implications of myeloid‐derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus‐related hepatocellular carcinoma. Journal of Medical Virology 2019; 91(7) doi: 10.1002/jmv.25428
|
| 39 |
Joey McGregor, Joshua M. Hardy, Chan-Sien Lay, Irene Boo, Michael Piontek, Manfred Suckow, Fasséli Coulibaly, Pantelis Poumbourios, Rob J. Center, Heidi E. Drummer, J.-H. James Ou. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs. Journal of Virology 2022; 96(5) doi: 10.1128/jvi.01675-21
|
| 40 |
Rosalyn Casey, Deena Blumenkrantz, Kerry Millington, Damien Montamat-Sicotte, Onn Min Kon, Melissa Wickremasinghe, Samuel Bremang, Murphy Magtoto, Saranya Sridhar, David Connell, Ajit Lalvani, Denise L. Doolan. Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis. PLoS ONE 2010; 5(12) doi: 10.1371/journal.pone.0015619
|
| 41 |
E. John Wherry, Paul Klenerman. The Immune Response to Infection. 2014; doi: 10.1128/9781555816872.ch20
|
| 42 |
Mohamed Abdel‐Samiee, Mohamed I. Youssef, Fathy Elghamry, Mahmoud Bazeed, Mohamed Al‐Shorbagy, Helmy Shalaby, Hossam Shabana, Eman Abdelsameea, Hesham El Sayed Lashin, Hossam M. Farid El Zamek, Tarek Esam, Mohammad AbdElhameed Ahmed Alwaseef, Housam Ahmed Helmy, Feras Almarshad, Fatma A. Khalaf, Badawy W. AboBakr Yossef, Arafat Kassem, Basant Mostafa Gabr, Ahmed Abdelfattah, Hind S. AboShabaan, Galal Abdelhameed Aboufarrag, Marwa M. Omar, Mohammed Saied Bakeer, Mohammed S. Imam, Essam S. Ibrahim, Shimaa Y Kamel, Talaat Allisy, Omima Sayed Mohammed, Ali Farahat, Mohsen M. El‐Khayat, Mohamed Abdelrafaa Hassan Sekeen, Eman Mohammed Zaher, Ashraf Said, Ahmed Abuamer, Essam Elmahdi. A multicentric and nationwide predictive study role of T cell sub‐population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients. Journal of Medical Virology 2023; 95(12) doi: 10.1002/jmv.29248
|
| 43 |
Kyung Hee Kang, Yasuhiro Yamamura, Maria P. Carlos, Nicolas Karvelas, In-Sup Kim, Deepa Sunkara, Rebecca Rivera, Murray B. Gardner, David E. Anderson, Francisco Diaz-Mitoma, José V. Torres, Juan P. Marquez. Synthetic Antigens Representing the Antigenic Variation of Human Hepatitis C Virus. Viral Immunology 2010; 23(5) doi: 10.1089/vim.2010.0043
|
| 44 |
Samaa T. Gobran, Petronela Ancuta, Naglaa H. Shoukry. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.726419
|
| 45 |
Naglaa H. Shoukry. Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV. Viruses 2021; 13(9) doi: 10.3390/v13091871
|
| 46 |
Michaela Lucas, Pooja Deshpande, Ian James, Andri Rauch, Katja Pfafferott, Elouise Gaylard, Shahzma Merani, Anne Plauzolles, Andrew Lucas, Wyatt McDonnell, Spyros Kalams, Mark Pilkinton, Cody Chastain, Louise Barnett, Amy Prosser, Simon Mallal, Karen Fitzmaurice, Heidi Drummer, M. Azim Ansari, Vincent Pedergnana, Ellie Barnes, Mina John, Dermot Kelleher, Paul Klenerman, Silvana Gaudieri. Evidence of CD4+ T cell-mediated immune pressure on the Hepatitis C virus genome. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25559-6
|
| 47 |
H. J. Hartling, J. C. Gaardbo, A. Ronit, M. Salem, M. Laye, M. R. Clausen, K. Skogstrand, J. Gerstoft, H. Ullum, S. D. Nielsen. Impaired Thymic Output in Patients with Chronic HepatitisCVirus Infection. Scandinavian Journal of Immunology 2013; 78(4) doi: 10.1111/sji.12096
|
| 48 |
J. F. Möller, B. Möller, B. Wiedenmann, T. Berg, E. Schott. CD154, a marker of antigen‐specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection. Journal of Viral Hepatitis 2011; 18(7) doi: 10.1111/j.1365-2893.2010.01430.x
|
| 49 |
Xiufeng Wang, Yunqing Zhong, Rongzhen Zhang, Yueqiao Chen, Minggang Wang, Chao Lv, Dewen Mao, Ruchika Garg. Wenyang Huazhuo Tuihuang Formula Inhibits the Th17/Treg Cell Imbalance and Protects against Acute-on-Chronic Liver Failure. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/5652172
|
| 50 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1) doi: 10.3390/vaccines8010090
|